Role of Hepatitis C Virus Infection on Lymphoproliferative Disorders after Non-liver Transplantation

References (39)

1. 1 Malignant lymphomas in transplantation patients.
2. 2 Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma [DOI]
3. 3 Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial [DOI]
4. 4 Hepatitis C Virus Infection in Patients with B-Cell Non-Hodgkin Lymphoma [DOI]
5. 5 Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders [DOI]
6. 6 Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score [DOI]
7. 7 Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors [DOI]
8. 8 Prevalence of hepatitis B or C virus infections in patients with non‐Hodgkin's lymphoma [DOI]
9. 9 The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.
10. 10 AN INCREASED INCIDENCE OF EPSTEIN-BARR VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG CHILDREN ON FK506 AFTER LIVER TRANSPLANTATION1 [DOI]
11. 11 Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
12. 12 Clonal B‐cell expansions in peripheral blood of HCV‐infected patients [DOI]
13. 13 The spectrum of extrahepatic manifestations in hepatitis C virus infection [DOI]
14. 14 Mucosa-Associated Lymphoid Tissue-Type Lymphomas Occurring in Post-Transplantation Patients [DOI]
15. 15 Clinical Usefulness of FDG-PET/CT Scan Imaging in the Management of Posttransplant Lymphoproliferative Disease [DOI]
16. 16 Hepatitis B and C virus infection in Romanian non‐Hodgkin's lymphoma patients [DOI]
17. 17 Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection? [DOI]
18. 18 High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in Italy [DOI]
19. 19 De novo malignancy following liver transplantation: a single-center study.
20. 20 Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation [DOI]
21. 21 Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients [DOI]
22. 22 Human Herpesvirus 8 and Epstein–Barr virus‐related monotypic large B‐cell lymphoproliferative disorder coexisting with mixed variant of Castleman's disease in a lymph node of a renal transplant recipient [DOI]
23. 23 Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study [DOI]
24. 24 Posttransplant Lymphoproliferative Disorders in Transplant Recipients [DOI]
25. 25 Significance of Epstein-Barr virus infection in the outcome of renal transplant patients with lymphoproliferative disorders.
26. 26 Hepatitis C Virus Infection in Patients With Overt B-Cell Non-Hodgkin’s Lymphoma in a French Center [DOI]
27. 27 HEPATITIS C VIRUS‐RELATED LYMPHOMAS [DOI]
28. 28 Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspective [DOI]
29. 29 Posttransplant Lymphoproliferative Disorder: Morphological Picture and Diagnostic Difficulties [DOI]
30. 30 Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey.
31. 31 Hepatitis C Virus Infection Can Affect Lymphoproliferative Disorders Only as a Cofactor for Epstein-Barr Virus in Liver Transplant Recipients: PTLD.Int Survey [DOI]
32. 32 Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern [DOI]
33. 33 Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients.
34. 34 The surgical implications of the posttransplant lymphoproliferative disorders.
35. 35 EBV-associated recurrent Hodgkin's disease after renal transplantation [DOI]
36. 36 Lymphoproliferative Disease After Lung and Heart-Lung Transplantation: First Description in Spain [DOI]
37. 37 Chronic liver disease and lymphoproliferative disorders in HCV-positive patients: a working hypothesis [DOI]
38. 38 Orthotopic liver transplantation, epstein-barr virus, cyclosporine, and lymphoproliferative disease: A growing concern [DOI]
39. 39 Multiple Pulmonary Nodules Caused by B-Cell Post-transplant Lymphoproliferative Disorder after Bone Marrow Transplantation: Monitoring Epstein-Barr Virus Viral Load [DOI]

Cited by 0

No indexed citations yet.